Background The impact of implantable defibrillator therapy on outcomes of patients with
nonischemic cardiomyopathy (NICM) who receive a cardiac resynchronization therapy …

Introduction With the recent publication of the negative DANISH trial, the mortality benefit of
the implantable cardioverter-defibrillator (ICD) has been put in question in patients with non …

Background: Recent studies have cast doubt on the benefit of cardiac resynchronization
therapy (CRT) with defibrillation (CRT-D) versus pacing (CRT-P) for patients with …

Background: Cardiac resynchronization therapy (CRT) represents a major medical advance
in patients with heart failure with electrical dyssynchrony to improve symptoms, reduce …

Background Recent studies have questioned the role of implanted cardiac defibrillators
(ICDs) in nonischemic cardiomyopathy (NICM). Cardiac resynchronization therapy (CRT) …

Objectives The aim of this study was to determine whether patients with heart failure with
reduced ejection fraction (HFrEF) due to nonischemic etiology eligible for cardiac …

Background Cardiac resynchronization therapy (CRT) is a major device therapy used to
treat patients suffering from heart failure (HF) and electrical asynchrony. It can improve HF …

Objectives: This study sought to evaluate the efficacy of implantable cardioverter-defibrillator
(ICD) therapy with or without cardiac resynchronization therapy (CRT) in patients with …

Aims There is a continuing debate as to whether cardiac resynchronization therapy-
defibrillation (CRT-D) is superior to CRT-pacing (CRT-P), particularly in patients with non …

Aims Prior studies have suggested that the benefit from primary preventive defibrillator
treatment for patients with nonischemic cardiomyopathyy, treated with cardiac …